Growth charts for Down's syndrome from birth to 18 years of age von Myrelid, Å, Gustafsson, J, Ollars, B, Annerén, G

Volltext

Asn540Lys mutation in fibroblast growth factor receptor 3 and phenotype in hypochondroplasia von Grigelioniené, G, Eklöf, O, Laurencikas, E, Ollars, B, Hertel, NT, Dumanski, JP, Hagenäs, L

Volltext

Asn540Lys mutation in fibroblast growth factor receptor 3 and phenotype in hypochondroplasia von GRIGELIONIENE, G, EKLÖF, O, LAURENCIKAS, E, OLLARS, B, HERTEL, N. T, DUMANSKI, J. P, HAGENÄS, L

Volltext

FIRST YEAR RESPONSE OF GROWTH IN SHORT CHILDREN WITH ACHONDROPLASIA OR HYPOCHONDROPLASIA TREATED WITH GROWTH HORMONE (GO) von Hagenäs, L, Ritzén, M, Eklöf, O, Neumeyer, L, Ollars, B, Karlsson, E, Müller, J, Hertel, N T

Volltext

VERY TALL CHILDREN HAVE SIMILAR 24-H-CH LEVELS AS SHORT CHILDREN BUT HIGHER CIRCULATING INSULIN AND LESS IGFBP-1 von Hagenäs, L, Rítzén, M, Ollars, B, Karlsson, E, Bang, P, Hall, K, Ivarsson, S, Aronson, S, Nilsson, N Ö, Westgren, U, Moëll, C, Kriström, B

Volltext

Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects a... von Boyd, PA, DeVigan, C, Khoshnood, B, Loane, M, Garne, E, Dolk, H

Volltext